Evidence map›Paper›PMID 33557110›Full record

ArticlePathogens (Basel, Switzerland)2021

Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients' Samples.

Saravana Murali Krishnan, Jayashri Mahalingam, Shanthi Sabarimurugan, Thiruvengadam Muthu, Baskar Venkidasamy, Kaveri Krishnasamy, Ashutosh Sharma, Sathishkumar Ramalingam

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Saravana Murali KrishnanPlant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641046, India.
Jayashri MahalingamInstitute of Health Education and Translational Sciences, Hyderabad 500026, India.
Shanthi SabarimuruganSchool of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.ORCID 0000-0003-2247-3426
Thiruvengadam MuthuDepartment of Applied Bioscience, Konkuk University, Seoul 05029, Korea.ORCID 0000-0003-0986-5484
Baskar VenkidasamyPlant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641046, India.
Kaveri KrishnasamyDepartment of Virology, King Institute of Preventive Medicine and Research, Chennai 600032, India.
Ashutosh SharmaCentre of Bioengineering, Technologico de Monterrey, Epigmenio Gonzalez #500, Fracc. San Pablo, Campus Queretaro, Santiago de Querétaro 76130, Queretaro, Mexico.ORCID 0000-0002-9000-1378
Sathishkumar RamalingamPlant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641046, India.ORCID 0000-0002-3145-7324
Bharathiar University · INInstituto Tecnológico de Querétaro · MXKing Institute of Preventive Medicine and Research · INKonkuk University · KRThe University of Western Australia · AUUniversity of Madras · IN

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR9119/MED/29/09/2007 DT: 12/11/2009
6 · The paper itself

Abstract

Chikungunya (CHIKV) and Dengue (DENV) viruses cause an acute febrile illness which is hard to clinically differentiate and treat since both exhibit similar symptoms. Hence, this study was aimed at identifying the expression profiles of cytokines on co-infected samples and compare with CHIKV and DENV mono-infected samples. Serum samples of 292 suspected patients during 2009-2011 were analyzed. The presence of primary (IgM)/secondary (IgG) antibodies and early NS1 Dengue antigens were confirmed by capture ELISA. Molecular diagnosis and serotypes were discriminated by RT-PCR, confirmed by sequencing. All the plasma samples were assayed for cytokine expression by BDTM cytometry bead array (CBA) and compared with independent mono-infection viral load. Among the tested samples, 82 were confirmed as Dengue positive; 52 through IgM (17.8%), and 30 through IgG (10.2%). Additionally, 186 samples were confirmed as Chikungunya, 96 through IgM (32.6%) and 92 through IgG (31.5%) ELISA, respectively. Interestingly, 19 patients were co-infection positive in which, only 6 were confirmed for CHIKV and 7 for DENV by RT-PCR. Among 8 cytokines, IL-2, IL-8, IFNα, IFN γ, and IL-12 were found to be significantly different between co-infected and CHIKV mono-infected patients and correlated with viral load. DENV viral load was correlated with cytokine expression and a significant difference in IL-2 and IL-12 was observed between DENV mono-infected and DENV and CHIKV co-infected patients. Results indicated that apart from serological and molecular confirmation, cytokines could be used as a specific biomarker for the diagnosis of DENV and CHIKV. In the future, the role of independent cytokines can be determined to understand the pathogenesis and etiology of these dreadful diseases.

Indexed as

ChikungunyaDengue viral loadELISAinflammatory cytokinesRT- PCR

Identifiers

PMID33557110
PMCPMC7913810
OpenAlexW3127428025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.